# Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma

> clinical trial · VERIFIED · 2026-08-31

Status: RECRUITING · Sponsor: Natalie Callander · Condition: Relapse Multiple Myeloma

- Company: Natalie Callander
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07479979

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.